Catalyst Wire Dossier Catalyst Wire Dossier

Synergy Everolimus-Eluting Stent

Everolimus-eluting stent · Boston Scientific
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Synergy Everolimus-Eluting Stent, covering 2015-06-02 to 2015-06-02. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome [Phase 4]

See pricing